Vfend (voriconazole), a new antifungal

July 2002

Pfizer will soon launch Vfend (voriconazole), a new antifungal.

It's in the same class as itraconazole (Sporanox).

Vfend will be an alternative to amphotericin B for life-threatening fungal infections.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

hear LOTS about HIPAA...the Health Insurance Portability and Accountability Act
Cholesterol statins might cause peripheral neuropathy
angiotensin receptor blockers (ARBs) might help prevent headaches
Geriatrics how to treat persistent pain in the elderly...due to arthritis, back pain, etc.
Diabetes when it's appropriate to use "alternate site testing" for measuring blood glucose
Dermatology Trental (pentoxifylline) will be used more for venous leg ulcers
Women's Health Should women stop taking oral contraceptives before surgery?
Women's Health Zoloft (sertraline) for premenstrual dysphoric disorder (PMDD)
Infectious Diseases Summer travelers are asking about international precautions
Infectious Diseases Vfend (voriconazole), a new antifungal
Gelclair, a new Rx for oral pain
Natural Medicines Nexrutine, an herbal ingredient being called a "natural COX-2 inhibitor
Natural Medicines astaxanthin (as-ta-ZAN-thin), an antioxidant that's popping up in many products
Men's Health men getting BOTH Proscar and an alpha-blocker for benign prostatic hyperplasia